Trials / Active Not Recruiting
Active Not RecruitingNCT04995822
Post Market Clinical Follow-up of EUROSTEM Femoral Stem
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 131 (estimated)
- Sponsor
- EUROS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
EUROSSTEM is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSTEM performances and safety
Detailed description
Post market observational study. This study is multicenter, prospective, non comparative.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | hip arthroplasty | Hip prosthesis surgery |
Timeline
- Start date
- 2021-05-21
- Primary completion
- 2022-11-06
- Completion
- 2032-11-06
- First posted
- 2021-08-09
- Last updated
- 2024-02-20
Locations
9 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04995822. Inclusion in this directory is not an endorsement.